Works matching IS 09395555 AND DT 2022 AND VI 101 AND IP 1

Results: 32

Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 1, doi. 10.1007/s00277-021-04690-x

By:

Ghanem, Paola;
Marrone, Kristen;
Shanbhag, Satish;
Brahmer, Julie R.;
Naik, Rakhi P.

Publication type:

Article

Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 11, doi. 10.1007/s00277-021-04637-2

By:

Patwardhan, Pallavi;
Landsteiner, Adrienne;
Lal, Lincy S.;
Geevarghese, Lincy;
Le, Lisa;
Nandal, Savita;
Cuker, Adam

Publication type:

Article

Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 147, doi. 10.1007/s00277-021-04687-6

By:

Mendes, Fernanda Rodrigues;
da Silva, Wellington Fernandes;
da Costa Bandeira de Melo, Raphael;
Silveira, Douglas Rafaele Almeida;
Velloso, Elvira Deolinda Rodrigues Pereira;
Rocha, Vanderson;
Rego, Eduardo Magalhaes

Publication type:

Article

Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 139, doi. 10.1007/s00277-021-04683-w

By:

Kuykendall, Andrew T.;
Sun, Libo;
Mascarenhas, John;
Kiladjian, Jean-Jacques;
Vannucchi, Alessandro M.;
Wang, Julia;
Xia, Qi;
Zhu, Eugene;
Feller, Faye;
Rizo, Aleksandra;
Bussolari, Jacqueline;
Wan, Ying;
Komrokji, Rami

Publication type:

Article

Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 109, doi. 10.1007/s00277-021-04670-1

By:

Hou, Hsin-An;
Tzeng, Huey-En;
Liu, Hung-Yi;
Chou, Wen-Chien;
Tien, Hwei-Fang;
Chien, Li-Nien

Publication type:

Article

Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 131, doi. 10.1007/s00277-021-04682-x

By:

Verstovsek, Srdan;
Parasuraman, Shreekant;
Yu, Jingbo;
Shah, Anne;
Kumar, Shambhavi;
Xi, Ann;
Harrison, Claire

Publication type:

Article

Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 177, doi. 10.1007/s00277-021-04676-9

By:

Konuma, Takaaki;
Ooi, Jun;
Nagayama, Hitomi;
Tomonari, Akira;
Tsukada, Nobuhiro;
Kato, Seiko;
Kawakita, Toshiro;
Isobe, Masamichi;
Monna-Oiwa, Maki;
Tojo, Arinobu;
Iseki, Tohru;
Takahashi, Satoshi

Publication type:

Article

Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 59, doi. 10.1007/s00277-021-04685-8

By:

del Río-Garma, Julio;
Bobillo, Sabela;
de la Rubia, Javier;
Pascual, Cristina;
García-Candel, Faustino;
García-Gala, Jose M.;
Gonzalez, Reyes;
Abril, Laura;
Vidan, Julia;
Gomez, Maria Jesús;
Peña, Francisco;
Arbona, Cristina;
Martín-Sanchez, Jesús;
Moreno, Gemma;
Romón, Iñigo;
Viejo, Aurora;
Oliva, Ana;
Linares, Mónica;
Salinas, Ramón;
Pérez, Sonia

Publication type:

Article

Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 99, doi. 10.1007/s00277-021-04675-w

By:

Ho, Ryan C. W.;
Chan, Thomas S. Y.;
Au-Yeung, Rex;
Tang, Karen H. K.;
Hwang, Yu-Yan;
Tse, Eric;
Kwong, Yok-Lam

Publication type:

Article

Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 91, doi. 10.1007/s00277-021-04671-0

By:

Wang, Xiaojun;
Miao, Yi;
Cao, Zheng;
Zheng, Shan;
Xue, Xuemin;
Feng, Xiaoli

Publication type:

Article

Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 191, doi. 10.1007/s00277-021-04681-y

By:

Salamonowicz-Bodzioch, Małgorzata;
Frączkiewicz, Jowita;
Czyżewski, Krzysztof;
Zając-Spychała, Olga;
Gorczyńska, Ewa;
Wróbel, Grażyna;
Kazanowska, Bernarda;
Sęga-Pondel, Dorota;
Węcławek-Tompol, Jadwiga;
Ussowicz, Marek;
Kałwak, Krzysztof;
Wysocki, Mariusz;
Dziedzic, Magdalena;
Wachowiak, Jacek;
Zaucha-Prażmo, Agnieszka;
Kowalczyk, Jerzy;
Goździk, Jolanta;
Styczyński, Jan

Publication type:

Article

The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 21, doi. 10.1007/s00277-021-04668-9

By:

Davis, Mitchell;
Movahed, Mohammad Reza;
Hashemzadeh, Mehrtash;
Hashemzadeh, Mehrnoosh

Publication type:

Article

Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 35, doi. 10.1007/s00277-021-04667-w

By:

Yildirim, Nazim;
Unal, Selma;
Yalcinkaya, Ahmet;
Karahan, Feryal;
Oztas, Yesim

Publication type:

Article

Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 119, doi. 10.1007/s00277-021-04674-x

By:

Zhao, Peng;
Ni, Ming;
Ma, Dan;
Fang, Qin;
Zhang, Yan;
Li, Yanju;
Huang, Yi;
Chen, Ying;
Chai, Xiao;
Zhan, Yun;
Li, Yan;
Kang, Qian;
Zhao, Mei;
Liu, Min;
Zhang, Fengqi;
Huang, Shisi;
Wen, Shuangshuang;
Deng, Bo;
Wang, Jishi

Publication type:

Article

miRNA profile and disease severity in patients with sickle cell anemia.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 27, doi. 10.1007/s00277-021-04665-y

By:

Biassi, Thaís Priscila;
Guerra-Shinohara, Elvira Maria;
Moretti, Patrícia Natália Silva;
de Freitas Dutra, Valeria;
Cabañas-Pedro, Ana Carolina;
Mecabo, Grazielle;
Colleoni, Gisele Wally Braga;
Figueiredo, Maria Stella

Publication type:

Article

Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies.

Published in:

2022

By:

Sakurai, Masatoshi;
Nannya, Yasuhito;
Yamazaki, Rie;
Yamaguchi, Kentaro;
Koda, Yuya;
Abe, Ryohei;
Yokoyama, Kenji;
Ogawa, Seishi;
Mori, Takehiko

Publication type:

Letter

Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 81, doi. 10.1007/s00277-021-04663-0

By:

Sokol, Juraj;
Guman, Tomas;
Chudej, Juraj;
Hlebaskova, Monika;
Stecova, Natalia;
Valekova, Lubica;
Kucerikova, Monika;
Stasko, Jan

Publication type:

Article

Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 43, doi. 10.1007/s00277-021-04646-1

By:

Abulhamail, Albraa;
AlShebli, Ahmad;
Merdad, Leeena;
Wali, Siraj;
Jastaniah, Wasil;
Abaalkhail, Bahaa

Publication type:

Article

Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 69, doi. 10.1007/s00277-021-04644-3

By:

Gupta, Anshul;
Desai, Nihar;
Sanjeev;
Chauhan, Priyanka;
Nityanand, Soniya;
Hashim, Zia;
Gupta, Mansi

Publication type:

Article

Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 165, doi. 10.1007/s00277-021-04664-z

By:

Hiramoto, Nobuhiro;
Yamazaki, Hirohito;
Nakamura, Yukinori;
Uchida, Naoyuki;
Murata, Makoto;
Kondo, Tadakazu;
Yoshioka, Satoshi;
Eto, Tetsuya;
Nishikawa, Akinori;
Kimura, Takafumi;
Ichinohe, Tatsuo;
Atsuta, Yoshiko;
Onishi, Yasushi;
Suzuki, Ritsuro;
Mori, Takehiko

Publication type:

Article

Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.

Published in:

2022

By:

Tartaglione, Immacolata;
Manara, Renzo;
di Concilio, Rosanna;
Quarta, Antonella;
Ruffo, Giovan Battista;
De Michele, Elisa;
Ammendola, Federica;
Foderini, Maria Vittoria;
Raimo, Simona;
Santangelo, Gabriella;
Perrotta, Silverio

Publication type:

Letter

Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre.

Published in:

Annals of Hematology, 2022, v. 101, n. 1, p. 155, doi. 10.1007/s00277-021-04658-x

By:

Leung, Garret M. K.;
Sim, Joycelyn P. Y.;
Hwang, Yu-Yan;
Chan, Thomas S. Y.;
Lie, Albert K. W.;
Tse, Eric;
Kwong, Yok-Lam

Publication type:

Article

The first case of a collision tumor of gastrointestinal stromal tumor and intravascular large B cell lymphoma.

Published in:

2022

By:

Yuan, Yueying;
Wang, En-Hua;
Wang, Liang

Publication type:

Letter

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19.

Published in:

2022

By:

Roncati, Luca;
Manenti, Antonio;
Fabbiani, Luca;
Malagoli, Claudia;
Nasillo, Vincenzo;
Lusenti, Beatrice;
Lupi, Massimo;
Zanelli, Giuliana;
Salviato, Tiziana;
Costantini, Matteo;
Trenti, Tommaso;
Maiorana, Antonio

Publication type:

Letter

Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia.

Published in:

2022

By:

Acquaviva, Gloria;
Nonne, Giovanna;
Murtas, Andrea;
Longu, Francesco;
Caocci, Giovanni;
La Nasa, Giorgio;
Fozza, Claudio

Publication type:

Letter

CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma.

Published in:

2022

By:

Gill, Harinder;
Au-Yeung, Rex;
Loong, Florence;
Kwong, Yok-Lam

Publication type:

Letter

Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.

Published in:

2022

By:

Debureaux, Pierre-Edouard;
Ruggiu, Mathilde;
Mathis, Stéphanie;
Mirouse, Adrien;
Dhouaieb, Bedis;
Cuccuini, Wendy;
Soulier, Jean;
Mariotte, Eric;
Lemaire, Pierre

Publication type:

Letter

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.

Published in:

2022

By:

Schlaweck, Sebastian;
Brossart, Peter;
Heine, Annkristin

Publication type:

Letter

Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib.

Published in:

2022

By:

Martín-Moro, Fernando;
García-Cosío, Mónica;
Marquet-Palomanes, Juan;
López-Gutiérrez, María;
Pian-Arias, Héctor;
López-Jiménez, Francisco Javier

Publication type:

Letter

Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients.

Published in:

2022

By:

Hosoi, Hiroki;
Murata, Shogo;
Mushino, Toshiki;
Tamura, Shinobu;
Sonoki, Takashi

Publication type:

Letter

Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study.

Published in:

2022

By:

Musallam, Khaled M.;
Cappellini, Maria Domenica;
Daar, Shahina;
Taher, Ali T.

Publication type:

Letter

Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study.

Published in:

2022

By:

Yamasaki, Satoshi;
Matsushima, Takumi;
Minami, Mariko;
Kadowaki, Masanori;
Takase, Ken;
Iwasaki, Hiromi

Publication type:

Letter